Pulmonary Nocardiosis in an Immunocompetent Patient with Cystic Fibrosis

Table 1

Antimicrobial susceptibility charts for Pseudomonas aeruginosa and Staphylococcus aureus from previous hospitalization.

(a) Pseudomonas aeruginosa (nonmucoid CF)

Antibiotic	Sensitivity
Amikacin	Susceptible
Method: KB
Aztreonam	Susceptible
Method: KB
Ceftazidime	Susceptible
Method: KB
Ciprofloxacin	Susceptible
Method: KB
Meropenem	Susceptible
Method: KB
Piperacillin	Susceptible
Method: KB
Ticarcillin	Intermediate
Method: KB
Tobramycin	Susceptible
Method: KB

(b) Staphylococcus aureus

Antibiotic	Sensitivity	Microscan
Ciprofloxacin	Resistant	>2
Method: MIC
Clindamycin	Resistant	>4
Method: MIC
Erythromycin	Resistant	>4
Method: MIC
Gentamicin	Susceptible	≤1
Method: MIC
Levofloxacin	Resistant	>4
Method: MIC
Moxifloxacin	Resistant	4
Method: MIC
Oxacillin	Susceptible
Method: MIC
Penicillin	Resistant	2
Method: MIC
Tetracycline	Resistant	>8
Method: MIC
Trimeth-Sulfamethox	Susceptible	≤0.5/9.5
Method: MIC
Vancomycin	Susceptible	1
Method: MIC